Rinucumab Antibody
Rinucumab (REGN 2176) is an IgG4-like monoclonal antibody targeting the PDGF-β receptor. It is utilized in research on age-related macular degeneration (AMD), with studies investigating its role in inhibiting pathological angiogenesis in both in vitro and in vivo models of ocular disease.
Product Specifications
Product Name Alternative
REGN2176, REGN 2176, PDGF
Target
PDGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
8.59 mg/mL
Purity
97.70% (May vary between batches)
Molecular Weight
145.58 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
